Visceral adiposity predicts post‐operative Crohn's disease recurrence
Summary Background Excessive visceral adipose tissue has been associated with poorer outcomes in patients with inflammatory bowel disease. Aim To determine whether body composition is associated with outcome in a prospective study of post‐operative Crohn's disease patients. Methods The POCER st...
Saved in:
Published in | Alimentary pharmacology & therapeutics Vol. 45; no. 9; pp. 1255 - 1264 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.05.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0269-2813 1365-2036 |
DOI | 10.1111/apt.14018 |
Cover
Loading…
Abstract | Summary
Background
Excessive visceral adipose tissue has been associated with poorer outcomes in patients with inflammatory bowel disease.
Aim
To determine whether body composition is associated with outcome in a prospective study of post‐operative Crohn's disease patients.
Methods
The POCER study evaluated management strategies for prevention of post‐operative Crohn's disease recurrence; subjects were enrolled after resection of all macroscopic Crohn's disease and were randomised to early endoscopy and possible treatment escalation, or standard care. The primary endpoint was endoscopic recurrence at 18 months. 44 subjects with cross‐sectional abdominal imaging were studied, and body composition analysis performed using established techniques to measure visceral adipose tissue area, subcutaneous adipose tissue area, and skeletal muscle area.
Results
The body composition parameter with the greatest variance was visceral adipose tissue. Regardless of treatment, all subjects with visceral adipose tissue/height2 >1.5 times the gender‐specific mean experienced endoscopic recurrence at 18 months (compared to 47%) [relative risk 2.1, 95% CI 1.5–3.0, P = 0.012]. Waist circumference correlated strongly with visceral adipose tissue area (ρ = 0.840, P < 0.001). Low skeletal muscle was prevalent (41% of patients), but did not predict endoscopic recurrence; however, appendicular skeletal muscle indices correlated inversely with faecal calprotectin (ρ = 0.560, P = 0.046).
Conclusions
Visceral adiposity is an independent risk factor for endoscopic recurrence of Crohn's disease after surgery. Sarcopenia correlates with inflammatory biomarkers. Measures of visceral adipose tissue may help to stratify risk in post‐operative management strategies.
Linked ContentThis article is linked to Holt et al, and Stidham and Waljee papers. To view these articles visit https://doi.org/10.1111/apt.14102 and https://doi.org/10.1111/apt.14069. |
---|---|
AbstractList | Summary
Background
Excessive visceral adipose tissue has been associated with poorer outcomes in patients with inflammatory bowel disease.
Aim
To determine whether body composition is associated with outcome in a prospective study of post‐operative Crohn's disease patients.
Methods
The POCER study evaluated management strategies for prevention of post‐operative Crohn's disease recurrence; subjects were enrolled after resection of all macroscopic Crohn's disease and were randomised to early endoscopy and possible treatment escalation, or standard care. The primary endpoint was endoscopic recurrence at 18 months. 44 subjects with cross‐sectional abdominal imaging were studied, and body composition analysis performed using established techniques to measure visceral adipose tissue area, subcutaneous adipose tissue area, and skeletal muscle area.
Results
The body composition parameter with the greatest variance was visceral adipose tissue. Regardless of treatment, all subjects with visceral adipose tissue/height2 >1.5 times the gender‐specific mean experienced endoscopic recurrence at 18 months (compared to 47%) [relative risk 2.1, 95% CI 1.5–3.0, P = 0.012]. Waist circumference correlated strongly with visceral adipose tissue area (ρ = 0.840, P < 0.001). Low skeletal muscle was prevalent (41% of patients), but did not predict endoscopic recurrence; however, appendicular skeletal muscle indices correlated inversely with faecal calprotectin (ρ = 0.560, P = 0.046).
Conclusions
Visceral adiposity is an independent risk factor for endoscopic recurrence of Crohn's disease after surgery. Sarcopenia correlates with inflammatory biomarkers. Measures of visceral adipose tissue may help to stratify risk in post‐operative management strategies.
Linked ContentThis article is linked to Holt et al, and Stidham and Waljee papers. To view these articles visit https://doi.org/10.1111/apt.14102 and https://doi.org/10.1111/apt.14069. BACKGROUNDExcessive visceral adipose tissue has been associated with poorer outcomes in patients with inflammatory bowel disease.AIMTo determine whether body composition is associated with outcome in a prospective study of post-operative Crohn's disease patients.METHODSThe POCER study evaluated management strategies for prevention of post-operative Crohn's disease recurrence; subjects were enrolled after resection of all macroscopic Crohn's disease and were randomised to early endoscopy and possible treatment escalation, or standard care. The primary endpoint was endoscopic recurrence at 18 months. 44 subjects with cross-sectional abdominal imaging were studied, and body composition analysis performed using established techniques to measure visceral adipose tissue area, subcutaneous adipose tissue area, and skeletal muscle area.RESULTSThe body composition parameter with the greatest variance was visceral adipose tissue. Regardless of treatment, all subjects with visceral adipose tissue/height2 >1.5 times the gender-specific mean experienced endoscopic recurrence at 18 months (compared to 47%) [relative risk 2.1, 95% CI 1.5-3.0, P = 0.012]. Waist circumference correlated strongly with visceral adipose tissue area (ρ = 0.840, P < 0.001). Low skeletal muscle was prevalent (41% of patients), but did not predict endoscopic recurrence; however, appendicular skeletal muscle indices correlated inversely with faecal calprotectin (ρ = 0.560, P = 0.046).CONCLUSIONSVisceral adiposity is an independent risk factor for endoscopic recurrence of Crohn's disease after surgery. Sarcopenia correlates with inflammatory biomarkers. Measures of visceral adipose tissue may help to stratify risk in post-operative management strategies. Excessive visceral adipose tissue has been associated with poorer outcomes in patients with inflammatory bowel disease. To determine whether body composition is associated with outcome in a prospective study of post-operative Crohn's disease patients. The POCER study evaluated management strategies for prevention of post-operative Crohn's disease recurrence; subjects were enrolled after resection of all macroscopic Crohn's disease and were randomised to early endoscopy and possible treatment escalation, or standard care. The primary endpoint was endoscopic recurrence at 18 months. 44 subjects with cross-sectional abdominal imaging were studied, and body composition analysis performed using established techniques to measure visceral adipose tissue area, subcutaneous adipose tissue area, and skeletal muscle area. The body composition parameter with the greatest variance was visceral adipose tissue. Regardless of treatment, all subjects with visceral adipose tissue/height >1.5 times the gender-specific mean experienced endoscopic recurrence at 18 months (compared to 47%) [relative risk 2.1, 95% CI 1.5-3.0, P = 0.012]. Waist circumference correlated strongly with visceral adipose tissue area (ρ = 0.840, P < 0.001). Low skeletal muscle was prevalent (41% of patients), but did not predict endoscopic recurrence; however, appendicular skeletal muscle indices correlated inversely with faecal calprotectin (ρ = 0.560, P = 0.046). Visceral adiposity is an independent risk factor for endoscopic recurrence of Crohn's disease after surgery. Sarcopenia correlates with inflammatory biomarkers. Measures of visceral adipose tissue may help to stratify risk in post-operative management strategies. Linked Content This article is linked to Holt et al, and Stidham and Waljee papers. To view these articles visit https://doi.org/10.1111/apt.14102 and https://doi.org/10.1111/apt.14069 . |
Author | Hamilton, A. L. Holt, D. Q. Strauss, B. J. G. De Cruz, P. Moore, G. T. Kamm, M. A. |
Author_xml | – sequence: 1 givenname: D. Q. orcidid: 0000-0001-7752-6279 surname: Holt fullname: Holt, D. Q. email: darcy.holt@monashhealth.org organization: Monash University – sequence: 2 givenname: G. T. surname: Moore fullname: Moore, G. T. organization: Monash University – sequence: 3 givenname: B. J. G. surname: Strauss fullname: Strauss, B. J. G. organization: Monash University – sequence: 4 givenname: A. L. orcidid: 0000-0002-1627-2057 surname: Hamilton fullname: Hamilton, A. L. organization: University of Melbourne – sequence: 5 givenname: P. surname: De Cruz fullname: De Cruz, P. organization: University of Melbourne – sequence: 6 givenname: M. A. surname: Kamm fullname: Kamm, M. A. organization: University of Melbourne |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28244124$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1KAzEUhYMotlYXvoAMuFAXY3PTTJpZSvEPCrpQtyHN3MGU6WRMZpTufASf0Scx2nYjms0l8J3Dvefske3a1UjIIdBziG-om_YcOAW5RfowElnK6Ehskz5lIk-ZhFGP7IUwp5SKMWW7pMck4xwY75PrJxsMel0lurCNC7ZdJo3Hwpo2JPHffr5_uCYCrX3FZOLdc30SksIG1AETj6bzHmuD-2Sn1FXAg_UckMery4fJTTq9u76dXExTwzMuU2B6ZrIMCmAzBljmErjMeImZNgwkK8aQacDCZFKO2UwKgQYKIUCKUrIxHw3I6cq38e6lw9CqxfcBVaVrdF1QEGVSilzkET3-hc5d5-u4nYKcxQA4UBqpozXVzRZYqMbbhfZLtYkoAsMVYLwLwWOpjG1jHK5uvbaVAqq-S1CxBPVTQlSc_VJsTP9i1-5vtsLl_6C6uH9YKb4AvZ-VLw |
CitedBy_id | crossref_primary_10_3390_bioengineering10101211 crossref_primary_10_3390_biom9120780 crossref_primary_10_3389_fnut_2022_826028 crossref_primary_10_1177_17562848231171962 crossref_primary_10_1186_s13244_024_01807_4 crossref_primary_10_1007_s10620_023_07838_z crossref_primary_10_3390_ijms21249564 crossref_primary_10_1007_s00384_025_04845_6 crossref_primary_10_1111_apt_17968 crossref_primary_10_1016_j_clnu_2020_01_001 crossref_primary_10_1002_ags3_12621 crossref_primary_10_3389_fmed_2020_00106 crossref_primary_10_4103_sjg_sjg_30_21 crossref_primary_10_1093_ibd_izy278 crossref_primary_10_1093_ecco_jcc_jjac041 crossref_primary_10_1093_ecco_jcc_jjad054 crossref_primary_10_62347_ZPZR8134 crossref_primary_10_1016_j_gastha_2023_08_020 crossref_primary_10_1093_ibd_izaa306 crossref_primary_10_1007_s10620_021_07002_5 crossref_primary_10_1007_s10620_024_08504_8 crossref_primary_10_3390_nu10091192 crossref_primary_10_14309_ctg_0000000000000407 crossref_primary_10_3390_jcm12144713 crossref_primary_10_1186_s13063_020_4105_x crossref_primary_10_2174_1389450120666190320110809 crossref_primary_10_1007_s10151_025_03110_w crossref_primary_10_1093_ibd_izac120 crossref_primary_10_1007_s11938_024_00453_5 crossref_primary_10_1097_MOG_0000000000001025 crossref_primary_10_1186_s13244_022_01293_6 crossref_primary_10_1093_ecco_jcc_jjy003 crossref_primary_10_1093_ecco_jcc_jjy124 crossref_primary_10_2174_1381612826666200427090127 crossref_primary_10_4166_kjg_2018_71_6_308 crossref_primary_10_1016_j_dld_2023_09_008 crossref_primary_10_1093_crocol_otaa064 crossref_primary_10_1111_apt_16069 crossref_primary_10_3390_nu15173824 crossref_primary_10_1111_apt_18040 crossref_primary_10_1371_journal_pone_0180036 crossref_primary_10_1016_j_mri_2023_01_005 crossref_primary_10_1093_ecco_jcc_jjab005 crossref_primary_10_1097_MEG_0000000000002839 crossref_primary_10_3390_ijms22084226 crossref_primary_10_3748_wjg_v25_i28_3823 crossref_primary_10_1016_j_dld_2020_06_024 crossref_primary_10_1038_s41430_021_00953_y crossref_primary_10_1016_j_clnu_2023_05_002 crossref_primary_10_1111_apt_15721 crossref_primary_10_1007_s40272_019_00361_7 crossref_primary_10_1016_j_nut_2022_111959 crossref_primary_10_1186_s12876_022_02327_5 crossref_primary_10_3390_nu13041378 crossref_primary_10_1111_apt_16456 crossref_primary_10_2147_JIR_S344563 crossref_primary_10_3390_biomedicines12061218 crossref_primary_10_3390_life12020272 crossref_primary_10_1016_j_ejrad_2023_110766 crossref_primary_10_1093_gastro_goac044 crossref_primary_10_1111_obr_12875 crossref_primary_10_1016_j_crad_2024_106786 crossref_primary_10_1016_j_surg_2024_02_025 crossref_primary_10_1007_s00384_021_03968_w crossref_primary_10_1186_s13244_023_01581_9 crossref_primary_10_1007_s00535_019_01634_1 crossref_primary_10_3390_nu14173460 crossref_primary_10_14309_ctg_0000000000000233 crossref_primary_10_3390_cells8060628 crossref_primary_10_1080_14656566_2023_2232726 crossref_primary_10_1186_s13244_021_01083_6 crossref_primary_10_3390_jpm13071029 crossref_primary_10_1007_s00384_023_04413_w crossref_primary_10_1007_s00384_023_04437_2 crossref_primary_10_1016_j_ejrad_2023_111144 crossref_primary_10_1111_apt_17498 crossref_primary_10_1038_s41575_022_00619_5 crossref_primary_10_3390_gastroent15030050 crossref_primary_10_3390_jcm10184214 crossref_primary_10_1093_nutrit_nuab028 crossref_primary_10_1016_j_ajpath_2022_03_006 crossref_primary_10_1111_apt_14069 crossref_primary_10_1111_apt_14102 crossref_primary_10_1155_2017_1215035 crossref_primary_10_1177_20406223231189072 crossref_primary_10_1186_s13244_024_01640_9 crossref_primary_10_1097_MEG_0000000000002675 crossref_primary_10_1016_j_isci_2024_111517 crossref_primary_10_4240_wjgs_v16_i3_740 crossref_primary_10_1093_ibd_izad227 |
Cites_doi | 10.1038/oby.2003.3 10.1053/j.gastro.2015.01.026 10.1111/apt.13353 10.1053/j.gastro.2011.01.055 10.1093/ecco-jcc/jjw136 10.1002/ibd.20504 10.1016/j.anaerobe.2013.03.011 10.1093/ecco-jcc/jjv058 10.1097/MIB.0000000000000503 10.1016/j.bbi.2011.02.010 10.1111/codi.13128 10.1053/j.gastro.2014.01.058 10.1038/nm.2627 10.1038/sj.ijo.0803696 10.1038/nri2921 10.1097/MIB.0000000000000527 10.1002/ibd.20932 10.1002/ibd.21825 10.1053/gast.2003.50106 10.1159/000365359 10.1111/j.1365-2036.2012.05002.x 10.1136/gut.47.4.465 10.1016/0002-9343(52)90025-9 10.1111/apt.12743 10.1111/j.1365-2036.2008.03774.x 10.1111/apt.13156 10.1016/j.dld.2016.02.023 10.1016/j.endonu.2013.10.004 10.3748/wjg.v22.i14.3860 10.3109/00365521.2016.1161069 10.1016/j.clnu.2015.07.005 10.1038/nrrheum.2014.193 10.1080/003655298750026985 10.1093/oxfordjournals.aje.a009520 10.1016/0016-5085(90)90613-6 10.1016/S0140-6736(14)61908-5 10.2183/pjab.86.131 10.1111/j.1463-1318.2012.03168.x 10.1172/JCI200319246 10.1097/MIB.0000000000000224 10.1259/bjr/80083156 10.1053/j.gastro.2016.02.072 10.1007/s10620-016-4045-1 10.1111/jgh.13677 10.1139/H08-075 10.1152/jappl.1997.83.1.229 10.1016/S1873-9946(14)60535-3 10.1016/S0016-5085(99)70552-4 10.1002/ibd.21903 10.1097/00004728-199611000-00013 10.1093/ajcn/80.2.271 10.1002/bjs.1800790934 10.1111/apt.12831 10.1111/apt.12372 10.1136/gut.2005.082925 10.1016/j.cgh.2011.05.005 10.1136/gut.2009.177782 10.1210/jc.2003-030608 10.1038/oby.2007.573 10.1111/codi.12798 10.1148/radiology.211.1.r99ap15283 |
ContentType | Journal Article |
Copyright | 2017 John Wiley & Sons Ltd 2017 John Wiley & Sons Ltd. Copyright © 2017 John Wiley & Sons Ltd |
Copyright_xml | – notice: 2017 John Wiley & Sons Ltd – notice: 2017 John Wiley & Sons Ltd. – notice: Copyright © 2017 John Wiley & Sons Ltd |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TK 7U9 H94 K9. M7N 7X8 |
DOI | 10.1111/apt.14018 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Neurosciences Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Neurosciences Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2036 |
EndPage | 1264 |
ExternalDocumentID | 28244124 10_1111_apt_14018 APT14018 |
Genre | article Randomized Controlled Trial Journal Article |
GrantInformation_xml | – fundername: Crohn's and Colitis Australia |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DTERQ E3Z EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EST ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FZ0 G-S G.N GODZA GX1 H.X HF~ HGLYW HVGLF HZI HZ~ IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK0 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TR2 TUS UB1 V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YOC ZZTAW ~IA ~WT AAYXX AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7T5 7TK 7U9 AAMMB AEFGJ AGXDD AIDQK AIDYY H94 K9. M7N 7X8 |
ID | FETCH-LOGICAL-c4548-12abc551d12b21ef9814854fe5ac2182d715a1edc58872b866ec1d66186f82743 |
IEDL.DBID | DR2 |
ISSN | 0269-2813 |
IngestDate | Thu Jul 10 18:55:46 EDT 2025 Fri Jul 25 10:10:46 EDT 2025 Wed Feb 19 02:43:49 EST 2025 Tue Jul 01 02:22:19 EDT 2025 Thu Apr 24 22:59:13 EDT 2025 Wed Jan 22 16:54:02 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2017 John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4548-12abc551d12b21ef9814854fe5ac2182d715a1edc58872b866ec1d66186f82743 |
Notes | https://doi.org/10.1111/apt.14102 https://doi.org/10.1111/apt.14069 Linked Content This article is linked to Holt et al, and Stidham and Waljee papers. To view these articles visit and . ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0001-7752-6279 0000-0002-1627-2057 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14018 |
PMID | 28244124 |
PQID | 1922444100 |
PQPubID | 2045200 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1872886969 proquest_journals_1922444100 pubmed_primary_28244124 crossref_citationtrail_10_1111_apt_14018 crossref_primary_10_1111_apt_14018 wiley_primary_10_1111_apt_14018_APT14018 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 2017 |
PublicationDateYYYYMMDD | 2017-05-01 |
PublicationDate_xml | – month: 05 year: 2017 text: May 2017 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Chichester |
PublicationTitle | Alimentary pharmacology & therapeutics |
PublicationTitleAlternate | Aliment Pharmacol Ther |
PublicationYear | 2017 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 1990; 99 1997; 83 2000; 47 2015; 148 2013; 24 2009; 82 2015; 385 2011; 11 2012; 18 2008; 32 2008; 33 2014; 61 2003; 112 2016; 35 2003; 11 2009; 58 2013; 15 2015; 42 2015; 41 2008; 28 1999; 211 2011; 25 2004; 80 2014; 8 2003; 124 2016; 48 2009; 15 1996; 20 2003; 88 2016; 150 2015; 17 1952; 13 2015; 11 2008; 14 2016; 51 1992; 79 2016; 18 2012; 35 2015; 9 2014; 40 2007; 56 2007; 15 2011; 9 2010; 86 2013; 38 2017; 11 2015; 21 2016 2016; 61 1998; 147 2014; 39 1999; 117 2011; 140 1998; 33 2016; 22 2014; 31 2014; 146 e_1_2_8_28_1 e_1_2_8_24_1 e_1_2_8_47_1 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_3_1 e_1_2_8_5_1 e_1_2_8_7_1 e_1_2_8_9_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_62_1 e_1_2_8_41_1 e_1_2_8_60_1 e_1_2_8_17_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_59_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_57_1 e_1_2_8_32_1 e_1_2_8_55_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_53_1 e_1_2_8_51_1 e_1_2_8_30_1 e_1_2_8_29_1 e_1_2_8_25_1 e_1_2_8_46_1 e_1_2_8_27_1 e_1_2_8_48_1 e_1_2_8_2_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_8_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_23_1 e_1_2_8_44_1 e_1_2_8_63_1 e_1_2_8_40_1 e_1_2_8_61_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_58_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_56_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_54_1 e_1_2_8_52_1 e_1_2_8_50_1 28503867 - Aliment Pharmacol Ther. 2017 Jun;45(12 ):1551-1552 28503865 - Aliment Pharmacol Ther. 2017 Jun;45(12 ):1552-1553 |
References_xml | – volume: 147 start-page: 755 year: 1998 end-page: 63 article-title: Epidemiology of sarcopenia among the elderly in New Mexico publication-title: Am J Epidemiol – volume: 11 start-page: 86 year: 2015 end-page: 97 article-title: Exercise as an anti‐inflammatory therapy for rheumatic diseases‐myokine regulation publication-title: Nat Rev Rheumatol – volume: 24 start-page: 117 year: 2013 end-page: 20 article-title: Diet, the human gut microbiota, and IBD publication-title: Anaerobe – volume: 11 start-page: 85 year: 2011 end-page: 97 article-title: Adipokines in inflammation and metabolic disease publication-title: Nat Rev Immunol – volume: 47 start-page: 465 year: 2000 end-page: 6 article-title: Specific targeting of IL‐6 signalling pathway: a new way to treat IBD? publication-title: Gut – volume: 38 start-page: 213 year: 2013 end-page: 25 article-title: Systematic review: body composition in adults with inflammatory bowel disease publication-title: Aliment Pharmacol Ther – volume: 42 start-page: 867 year: 2015 end-page: 79 article-title: Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high‐risk patients ‐ a POCER study analysis publication-title: Aliment Pharmacol Ther – volume: 146 start-page: 1564 year: 2014 end-page: 72 article-title: Diet and the intestinal microbiome: associations, functions, and implications for health and disease publication-title: Gastroenterology – volume: 58 start-page: 1218 year: 2009 end-page: 25 article-title: Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease publication-title: Gut – volume: 33 start-page: 956 year: 1998 end-page: 60 article-title: Body composition by dual‐energy X‐ray absorptiometry in patients with Crohn's disease publication-title: Scand J Gastroenterol – volume: 21 start-page: 468 year: 2015 end-page: 75 article-title: Histologic features predicting postoperative Crohn's disease recurrence publication-title: Inflamm Bowel Dis – volume: 80 start-page: 271 year: 2004 end-page: 8 article-title: Visceral adipose tissue: relations between single‐slice areas and total volume publication-title: Am J Clin Nutr – volume: 22 start-page: 3860 year: 2016 end-page: 8 article-title: Cost‐effectiveness of Crohn's disease post‐operative care publication-title: World J Gastroenterol – volume: 82 start-page: 123 year: 2009 end-page: 30 article-title: Whole‐body adipose tissue analysis: comparison of MRI, CT and dual energy X‐ray absorptiometry publication-title: Br J Radiol – volume: 61 start-page: 1268 year: 2016 end-page: 81 article-title: Gut microbiota of nonalcoholic fatty liver disease publication-title: Dig Dis Sci – volume: 35 start-page: 924 year: 2016 end-page: 7 article-title: Sarcopenia is associated with an increased inflammatory response to surgery in colorectal cancer publication-title: Clin Nutr – volume: 56 start-page: 577 year: 2007 end-page: 83 article-title: Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? publication-title: Gut – volume: 88 start-page: 5468 year: 2003 end-page: 72 article-title: Effects of growth hormone secretion on body composition in patients with Crohn's disease publication-title: J Clin Endocrinol Metab – volume: 18 start-page: 163 year: 2016 end-page: 72 article-title: Association between high visceral fat area and postoperative complications in patients with Crohn's disease following primary surgery publication-title: Colorectal Dis – volume: 18 start-page: 758 year: 2012 end-page: 77 article-title: Postoperative recurrent luminal Crohn's disease: a systematic review publication-title: Inflamm Bowel Dis – volume: 21 start-page: 2590 year: 2015 end-page: 7 article-title: Visceral adipose tissue in patients with Crohn's disease correlates with disease activity, inflammatory markers, and outcome publication-title: Inflamm Bowel Dis – volume: 35 start-page: 625 year: 2012 end-page: 33 article-title: Review article: the natural history of postoperative Crohn's disease recurrence publication-title: Aliment Pharmacol Ther – volume: 148 start-page: 938 year: 2015 end-page: 47 article-title: Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery publication-title: Gastroenterology – volume: 15 start-page: 187 year: 2013 end-page: 97 article-title: Postoperative recurrence of Crohn's disease: impact of endoscopic monitoring and treatment step‐up publication-title: Colorectal Dis – volume: 11 start-page: 191 year: 2017 end-page: 203 article-title: Microbial factors associated with postoperative Crohn's disease Recurrence publication-title: J Crohns Colitis – volume: 79 start-page: 955 year: 1992 end-page: 8 article-title: Fat‐wrapping in Crohn's disease: pathological basis and relevance to surgical practice publication-title: Br J Surg – volume: 33 start-page: 997 year: 2008 end-page: 1006 article-title: A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care publication-title: Appl Physiol Nutr Metab – year: 2016 article-title: Serologic antibodies in relation to outcome in post‐operative Crohn's disease publication-title: J Gastroenterol Hepatol – volume: 14 start-page: 1562 year: 2008 end-page: 8 article-title: Sarcopenia is prevalent in patients with Crohn's disease in clinical remission publication-title: Inflamm Bowel Dis – volume: 11 start-page: 5 year: 2003 end-page: 16 article-title: Adipose tissue quantification by imaging methods: a proposed classification publication-title: Obes Res – volume: 17 start-page: 225 year: 2015 end-page: 34 article-title: Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn's disease publication-title: Colorectal Dis – volume: 15 start-page: 370 year: 2007 end-page: 6 article-title: NIH ImageJ and Slice‐O‐Matic computed tomography imaging software to quantify soft tissue publication-title: Obesity – volume: 13 start-page: 583 year: 1952 end-page: 90 article-title: Regional ileitis; a pathologic and clinical entity publication-title: Am J Med – volume: 28 start-page: 545 year: 2008 end-page: 56 article-title: Meta‐analysis: factors predicting post‐operative recurrence with placebo therapy in patients with Crohn's disease publication-title: Aliment Pharmacol Ther – volume: 18 start-page: 363 year: 2012 end-page: 74 article-title: The cellular and signaling networks linking the immune system and metabolism in disease publication-title: Nat Med – volume: 61 start-page: 147 year: 2014 end-page: 52 article-title: Measurement of waist circumference for retrospective studies ‐ prospective validation of use of CT images to assess abdominal circumference publication-title: Endocrinol Nutr – volume: 8 start-page: S239 year: 2014 article-title: P415 MRI assessment of body composition in paediatric Crohn's disease; intra‐abdominal adipose tissue association with disease severity publication-title: J Crohns Colitis – volume: 9 start-page: 684 year: 2011 end-page: 7 article-title: Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn's disease publication-title: Clin Gastroenterol Hepatol – volume: 86 start-page: 131 year: 2010 end-page: 41 article-title: Establishment of a concept of visceral fat syndrome and discovery of adiponectin publication-title: Proc Jpn Acad Ser B – volume: 39 start-page: 1253 year: 2014 end-page: 65 article-title: Systematic review: the use of thiopurines or anti‐TNF in post‐operative Crohn's disease maintenance–progress and prospects publication-title: Aliment Pharmacol Ther – volume: 150 start-page: 1568 year: 2016 end-page: 78 article-title: Infliximab reduces endoscopic, but not clinical, recurrence of Crohn's disease after ileocolonic resection publication-title: Gastroenterology – volume: 385 start-page: 1406 year: 2015 end-page: 17 article-title: Crohn's disease management after intestinal resection: a randomised trial publication-title: Lancet – volume: 112 start-page: 1796 year: 2003 end-page: 808 article-title: Obesity is associated with macrophage accumulation in adipose tissue publication-title: J Clin Invest – volume: 99 start-page: 956 year: 1990 end-page: 63 article-title: Predictability of the postoperative course of Crohn's disease publication-title: Gastroenterology – volume: 15 start-page: 1499 year: 2009 end-page: 507 article-title: Predictive value and clinical significance of myenteric plexitis in Crohn's disease publication-title: Inflamm Bowel Dis – volume: 21 start-page: 1306 year: 2015 end-page: 13 article-title: Body fat composition assessment using analytic morphomics predicts infectious complications after bowel resection in Crohn's disease publication-title: Inflamm Bowel Dis – volume: 40 start-page: 322 year: 2014 end-page: 2 article-title: Letter: biological therapies are effective for prevention of post‐operative Crohn's disease recurrence publication-title: Aliment Pharmacol Ther – volume: 32 start-page: 100 year: 2008 end-page: 11 article-title: Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging publication-title: Int J Obes Relat Metab Disord – volume: 51 start-page: 842 year: 2016 end-page: 7 article-title: Body composition analysis using abdominal scans from routine clinical care in patients with Crohn's Disease publication-title: Scand J Gastroenterol – volume: 211 start-page: 283 year: 1999 end-page: 6 article-title: Abdominal fat: standardized technique for measurement at CT publication-title: Radiology – volume: 140 start-page: 1785 year: 2011 end-page: 94 article-title: Epidemiology and natural history of inflammatory bowel diseases publication-title: Gastroenterology – volume: 41 start-page: 895 year: 2015 end-page: 906 article-title: Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease publication-title: Aliment Pharmacol Ther – volume: 117 start-page: 73 year: 1999 end-page: 81 article-title: Inflammatory alterations in mesenteric adipose tissue in Crohn's disease publication-title: Gastroenterology – volume: 20 start-page: 940 year: 1996 end-page: 1 article-title: Clinical image. MR demonstration of submucosal fat in a patient with Crohn's disease publication-title: J Comput Assist Tomogr – volume: 31 start-page: 219 year: 2014 end-page: 24 article-title: Volumetric fat ratio and not body mass index is predictive of ileocolectomy outcomes in Crohn's disease patients publication-title: Dig Surg – volume: 48 start-page: 753 year: 2016 end-page: 8 article-title: Myenteric plexitis is a risk factor for endoscopic and clinical postoperative recurrence after ileocolonic resection in Crohn's disease publication-title: Dig Liver Dis – volume: 124 start-page: 795 year: 2003 end-page: 841 article-title: AGA technical review on osteoporosis in gastrointestinal diseases publication-title: Gastroenterology – volume: 9 start-page: 452 year: 2015 end-page: 62 article-title: Effect of intestinal resection on quality of life in Crohn's disease publication-title: J Crohns Colitis – volume: 18 start-page: 1340 year: 2012 end-page: 55 article-title: Serological antibodies in inflammatory bowel disease: a systematic review publication-title: Inflamm Bowel Dis – volume: 83 start-page: 229 year: 1997 end-page: 39 article-title: Appendicular skeletal muscle mass: effects of age, gender, and ethnicity publication-title: J Appl Physiol – volume: 25 start-page: 811 year: 2011 end-page: 6 article-title: Exercise‐induced myokines and their role in chronic diseases publication-title: Brain Behav Immun – ident: e_1_2_8_13_1 doi: 10.1038/oby.2003.3 – ident: e_1_2_8_26_1 doi: 10.1053/j.gastro.2015.01.026 – ident: e_1_2_8_24_1 doi: 10.1111/apt.13353 – ident: e_1_2_8_19_1 doi: 10.1053/j.gastro.2011.01.055 – ident: e_1_2_8_27_1 doi: 10.1093/ecco-jcc/jjw136 – ident: e_1_2_8_47_1 doi: 10.1002/ibd.20504 – ident: e_1_2_8_60_1 doi: 10.1016/j.anaerobe.2013.03.011 – ident: e_1_2_8_28_1 doi: 10.1093/ecco-jcc/jjv058 – ident: e_1_2_8_57_1 doi: 10.1097/MIB.0000000000000503 – ident: e_1_2_8_63_1 doi: 10.1016/j.bbi.2011.02.010 – ident: e_1_2_8_40_1 doi: 10.1111/codi.13128 – ident: e_1_2_8_59_1 doi: 10.1053/j.gastro.2014.01.058 – ident: e_1_2_8_17_1 doi: 10.1038/nm.2627 – ident: e_1_2_8_36_1 – ident: e_1_2_8_33_1 doi: 10.1038/sj.ijo.0803696 – ident: e_1_2_8_2_1 doi: 10.1038/nri2921 – ident: e_1_2_8_16_1 doi: 10.1097/MIB.0000000000000527 – ident: e_1_2_8_6_1 doi: 10.1002/ibd.20932 – ident: e_1_2_8_23_1 doi: 10.1002/ibd.21825 – ident: e_1_2_8_49_1 doi: 10.1053/gast.2003.50106 – ident: e_1_2_8_56_1 doi: 10.1159/000365359 – ident: e_1_2_8_20_1 doi: 10.1111/j.1365-2036.2012.05002.x – ident: e_1_2_8_3_1 doi: 10.1136/gut.47.4.465 – ident: e_1_2_8_4_1 doi: 10.1016/0002-9343(52)90025-9 – ident: e_1_2_8_42_1 doi: 10.1111/apt.12743 – ident: e_1_2_8_44_1 doi: 10.1111/j.1365-2036.2008.03774.x – ident: e_1_2_8_50_1 doi: 10.1111/apt.13156 – ident: e_1_2_8_7_1 doi: 10.1016/j.dld.2016.02.023 – ident: e_1_2_8_35_1 doi: 10.1016/j.endonu.2013.10.004 – ident: e_1_2_8_22_1 doi: 10.3748/wjg.v22.i14.3860 – ident: e_1_2_8_34_1 doi: 10.3109/00365521.2016.1161069 – ident: e_1_2_8_61_1 doi: 10.1016/j.clnu.2015.07.005 – ident: e_1_2_8_62_1 doi: 10.1038/nrrheum.2014.193 – ident: e_1_2_8_51_1 doi: 10.1080/003655298750026985 – ident: e_1_2_8_37_1 doi: 10.1093/oxfordjournals.aje.a009520 – ident: e_1_2_8_30_1 doi: 10.1016/0016-5085(90)90613-6 – ident: e_1_2_8_21_1 doi: 10.1016/S0140-6736(14)61908-5 – ident: e_1_2_8_10_1 doi: 10.2183/pjab.86.131 – ident: e_1_2_8_25_1 doi: 10.1111/j.1463-1318.2012.03168.x – ident: e_1_2_8_18_1 doi: 10.1172/JCI200319246 – ident: e_1_2_8_9_1 doi: 10.1097/MIB.0000000000000224 – ident: e_1_2_8_32_1 doi: 10.1259/bjr/80083156 – ident: e_1_2_8_45_1 doi: 10.1053/j.gastro.2016.02.072 – ident: e_1_2_8_58_1 doi: 10.1007/s10620-016-4045-1 – ident: e_1_2_8_29_1 doi: 10.1111/jgh.13677 – ident: e_1_2_8_14_1 doi: 10.1139/H08-075 – ident: e_1_2_8_38_1 doi: 10.1152/jappl.1997.83.1.229 – ident: e_1_2_8_53_1 doi: 10.1016/S1873-9946(14)60535-3 – ident: e_1_2_8_15_1 doi: 10.1016/S0016-5085(99)70552-4 – ident: e_1_2_8_43_1 doi: 10.1002/ibd.21903 – ident: e_1_2_8_41_1 doi: 10.1097/00004728-199611000-00013 – ident: e_1_2_8_12_1 doi: 10.1093/ajcn/80.2.271 – ident: e_1_2_8_5_1 doi: 10.1002/bjs.1800790934 – ident: e_1_2_8_46_1 doi: 10.1111/apt.12831 – ident: e_1_2_8_48_1 doi: 10.1111/apt.12372 – ident: e_1_2_8_52_1 doi: 10.1136/gut.2005.082925 – ident: e_1_2_8_55_1 doi: 10.1016/j.cgh.2011.05.005 – ident: e_1_2_8_8_1 doi: 10.1136/gut.2009.177782 – ident: e_1_2_8_39_1 doi: 10.1210/jc.2003-030608 – ident: e_1_2_8_31_1 doi: 10.1038/oby.2007.573 – ident: e_1_2_8_54_1 doi: 10.1111/codi.12798 – ident: e_1_2_8_11_1 doi: 10.1148/radiology.211.1.r99ap15283 – reference: 28503867 - Aliment Pharmacol Ther. 2017 Jun;45(12 ):1551-1552 – reference: 28503865 - Aliment Pharmacol Ther. 2017 Jun;45(12 ):1552-1553 |
SSID | ssj0006702 |
Score | 2.5084083 |
Snippet | Summary
Background
Excessive visceral adipose tissue has been associated with poorer outcomes in patients with inflammatory bowel disease.
Aim
To determine... Linked Content This article is linked to Holt et al, and Stidham and Waljee papers. To view these articles visit https://doi.org/10.1111/apt.14102 and... Excessive visceral adipose tissue has been associated with poorer outcomes in patients with inflammatory bowel disease. To determine whether body composition... BackgroundExcessive visceral adipose tissue has been associated with poorer outcomes in patients with inflammatory bowel disease.AimTo determine whether body... BACKGROUNDExcessive visceral adipose tissue has been associated with poorer outcomes in patients with inflammatory bowel disease.AIMTo determine whether body... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1255 |
SubjectTerms | Adipose tissue Adiposity Adult Biomarkers - metabolism Body composition Colonoscopy Crohn Disease - metabolism Crohn Disease - surgery Crohn's disease Endoscopy Feces - chemistry Female Humans Inflammatory bowel diseases Intestine Intra-Abdominal Fat - metabolism Leukocyte L1 Antigen Complex - metabolism Male Middle Aged Musculoskeletal system Postoperative Period Recurrence Risk Factors Sarcopenia Skeletal muscle Surgery Young Adult |
Title | Visceral adiposity predicts post‐operative Crohn's disease recurrence |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fapt.14018 https://www.ncbi.nlm.nih.gov/pubmed/28244124 https://www.proquest.com/docview/1922444100 https://www.proquest.com/docview/1872886969 |
Volume | 45 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB5MDiWXtkn6cOsGpRTai4x2tZJlejKmqQmklJIUHwpinyTEsY0lH5pTfkJ-Y39JZ1aPxG0DJTcJjdjd2Z3db3ZnvgV4Z108sIzJUMfOhYI7Gyqno1Axk2jEu1Zwync-_pJOTsXRNJl24GOTC1PxQ7QbbmQZfr4mA5equGPkcln2yTugRF-K1SJA9O2WOiod-HhDdDGGIc9YXLMKURRP--fmWvQXwNzEq37BOXwCP5qqVnEmF_11qfr66g8Wxwe25Sk8roFoMKpGzg507HwXHh3XR-178Pn7eaFpwyqQ5tyHdv0Mliv6XBYBvpe_rm8WS1sRhwfj1eJs_r4I6vOeYEXb-D6R8BmcHn46GU_C-taFUAt0X0LGpdKIowzjijPrhhl6TIlwNpGa6N7NgCWSWaMTnJ-4ytLUamZS4t13Gfq48XPYmi_m9iUEIlboHmodUdRnJpQUWmsjbOyUMRGXXfjQ6D_XNSU53YwxyxvXBBWTe8V04W0ruqx4OP4l1Gs6Ma9NscgRwiKEESyKunDQfr4kHc4onnixRhlsSZalw3TYhRdV57eloE8q6IpurKzvwvuLz0dfT_zDq_8XfQ3bnICCD6HswVa5Wts3CHNKte_H82_Lp_kc |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB4BlVoupUBbUigYhNReHHnXa8eRekEUCC1BCIWKC7K8L4GgSZQ4h3LiJ_Ab-SWdWT8KtEgVN1sea5-z-83s7DcAm8aGLcNY5qvQWl9wa3xpVeBLpiOFeNcITvedu4dx50R8O41Op-BLdRem4IeoHW6kGW69JgUnh_Q9Lc-GeZPMg2QaXlBGb1LLr8d_yKPilos4RCOj7fOEhSWvEMXx1L8-3I3-gpgPEavbcnbn4KyqbBFpctmc5LKprh_xOD63NW_gdYlFva1i8szDlOkvwMtuedq-CHs_LsaKfFZepi9cdNcvbziiz_nYw_f87uZ2MDQFd7i3PRqc9z-NvfLIxxuRJ9_dJXwLJ7s7ve2OXyZe8JVAC8ZnPJMKoZRmXHJmbDtBoykS1kSZIsZ33WJRxoxWES5RXCZxbBTTMVHv2wTN3PAdzPQHfbMEngglWohKBRT4mQiZCaWUFia0UuuAZw34XA1AqkpWckqOcZVW1gl2TOo6pgEbteiwoOL4l9BKNYppqY3jFFEsohjBgqAB6_Xnn9SHVxRSPJigDLYkSeJ23G7A-2L061LQLBWUpRsr68bw6eLTraOee_jw_6Jr8KrT6x6kB_uH35dhlhNucBGVKzCTjybmI6KeXK66yf0bUFf9NQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LTtwwFL2iVEJs-gQ6LaWhqlQ2GcWOk_GoKwRMoRSEKkAskKL4JUalM9FMZtGu-gl8I1_Se51HSykS6i5RbmT7-nWOfX0M8M66uGcZy0MdOxcK7myonI5CxUyiEe9awem888FhunsiPp0lZ3PwoTkLU-lDtAtu1DP8eE0dvDDuj06eF2WX2IF8AA9FGkliXttffmtHpT0fcIgcox9yyeJaVojCeNpfb05GtxDmTcDqZ5zBYzhv8loFmnztzkrV1T_-knH8z8I8gUc1Eg02q6bzFObs6BksHNR77c_h4-lwqmnFKsjN0Md2fQ-KCX0upwG-l9c_r8aFrZTDg63J-GL0fhrUGz7BhNbx_UnCJTgZ7Bxv7Yb1tQuhFshfQsZzpRFIGcYVZ9b1JVKmRDib5Jr03k2PJTmzRic4QHEl09RqZlIS3ncSSW68DPOj8ci-gEDECvmh1hGFfUqhcqG1NsLGThkT8bwDG43_M11rktPVGJdZw03QMZl3TAfetqZFJcTxL6PVphKzui9OM8SwiGEEi6IOrLefv5EPLymgeDxDGyyJlGk_7Xdgpar8NhUkpYLu6MbM-iq8O_ls8-jYP7y8v-kbWDjaHmSf9w73X8EiJ9DgwylXYb6czOxrhDylWvNN-xd60vvt |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Visceral+adiposity+predicts+post%E2%80%90operative+Crohn%27s+disease+recurrence&rft.jtitle=Alimentary+pharmacology+%26+therapeutics&rft.au=Holt%2C+D.+Q.&rft.au=Moore%2C+G.+T.&rft.au=Strauss%2C+B.+J.+G.&rft.au=Hamilton%2C+A.+L.&rft.date=2017-05-01&rft.issn=0269-2813&rft.eissn=1365-2036&rft.volume=45&rft.issue=9&rft.spage=1255&rft.epage=1264&rft_id=info:doi/10.1111%2Fapt.14018&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_apt_14018 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-2813&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-2813&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-2813&client=summon |